These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2784179)
21. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Bluestein HG; Williams GW; Steinberg AD Am J Med; 1981 Feb; 70(2):240-6. PubMed ID: 7468611 [TBL] [Abstract][Full Text] [Related]
22. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514 [TBL] [Abstract][Full Text] [Related]
23. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328 [TBL] [Abstract][Full Text] [Related]
34. Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein. Hanson VG; Horowitz M; Rosenbluth D; Spiera H; Puszkin S J Exp Med; 1992 Aug; 176(2):565-73. PubMed ID: 1500860 [TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus]. Lu XY; Ye S; Wang Y; Guo L; Chen XX; Fan W; Wang XD; Gu YY; Bao CD; Liu Q Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2462-6. PubMed ID: 17156673 [TBL] [Abstract][Full Text] [Related]
36. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus. Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203 [TBL] [Abstract][Full Text] [Related]
37. Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations. El-Garf A; Salah S; Shaarawy M; Zaki S; Anwer S J Rheumatol; 1996 Feb; 23(2):374-7. PubMed ID: 8882050 [TBL] [Abstract][Full Text] [Related]
38. The choroid plexus and system disease in mental illness. I. A new brain attack mechanism via the second blood--brain barrier. Rudin DO Biol Psychiatry; 1980 Aug; 15(4):517-39. PubMed ID: 6446942 [TBL] [Abstract][Full Text] [Related]
39. Environment and systemic lupus erythematosus: an overview. Sarzi-Puttini P; Atzeni F; Iaccarino L; Doria A Autoimmunity; 2005 Nov; 38(7):465-72. PubMed ID: 16373251 [TBL] [Abstract][Full Text] [Related]
40. Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. Sciascia S; Bertolaccini ML; Baldovino S; Roccatello D; Khamashta MA; Sanna G Autoimmun Rev; 2013 Jan; 12(3):426-9. PubMed ID: 22944298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]